跳至主要内容
临床试验/CTRI/2021/08/036020
CTRI/2021/08/036020已完成3 期

Evaluation of Vitamin E as an add on with standard therapy and its effect on plasma Pentraxin-3 in patients with chronic kidney disease on renal dialysis A Randomized control Clinical Trail

SRM Institute of Scince and Technology0 个研究点目标入组 152 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
152

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients of either gender, suffering from chronic kidney disease on hemodialysis at least for 3 months and age of 40 years to 70 years.
  • CKD patients on haemodialysis who were able to understand and agree for informed written informed consent for the participation in this study.
  • CKD patients on haemodialysis with Diabetes mellitus and hypertension as co-morbidities.

排除标准

  • CKD patients on haemodialysis who were disable or immobile.
  • CKD patients on haemodialysis with associated chronic liver disease (CLD), congestive heart failure (CHF), HIV, Active tuberculosis.
  • CKD patients on haemodialysis with immunosuppressive therapy and clinical signs of ongoing infection.
  • CKD patients with haemodialysis not on antioxidant therapy for last 3-6 months.

研究者

发起方
SRM Institute of Scince and Technology

相似试验